Skip to content

MERIDIAN BIOSCIENCE, INC.

CIK 0000794172

← back to feed
Revenue (TTM)
$324.25M
+4.8% YoY Q1 Jan 2023
Net Income (TTM)
$6.93M
−40.5% YoY Q1 Jan 2023
EPS Diluted (TTM)
$0.16
−40.7% YoY Q1 Jan 2023
Gross Margin
57.3%
Q1 Jan 2023
Operating Margin
6.7%
Q1 Jan 2023
Net Margin
2.1%
Q1 Jan 2023
Free Cash Flow (TTM)
$56.83M
Q1 Jan 2023
Cash
$74.1M
Q1 Jan 2023
Total Debt
$31M
Q1 Jan 2023
Shares Outstanding
44.04M sh
Q1 Jan 2023

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings